Improving the Medicine Supply Chain: An Imperative for Public Health Care

PLEASE NOTE
Older AT Kearney articles are no longer available. If you click through you will be taken to the Internet Archive site to find an archived copy.

Medicines play an important role in public health care programs, saving lives and drawing people to health facilities, where they can also receive preventive treatment. Medicines can also help keep health care costs down. Many insurance carriers would rather pay for drug treatment than for potentially risky and more expensive surgery. And the cost of complications from not treating illness with medicine in the early stages can ultimately be double or triple the expense.

But the high cost of medicines is putting increasing pressure on health care budgets. For example, in many industrialized nations the elderly population (those older than 65) is expected to double in the next 50 years. Usually, this segment of the population has approximately four times the health care expenditures of those under 65 years. Additionally, in many developing economies, the epidemiological profile is changing – evolving from infectious and less expensive diseases, which can be treated through massive national campaigns, to chronic degenerative diseases such as cancer and diabetes, which are more expensive to treat.

This paper discusses ways to improve the medicine supply chain in developing a seven-point solution to relieving pressure on health care budgets in these countries, the cost of medicine and improving key elements of the drug supply chain.

Like this content? Why not share it?
Share on FacebookTweet about this on TwitterGoogle+Share on LinkedInBuffer this pagePin on PinterestShare on Redditshare on TumblrShare on StumbleUpon

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.